
Chinese General Practice ›› 2027, Vol. 30 ›› Issue (01): 91-97.DOI: 10.12114/j.issn.1007-9572.2026.0120
• Article • Previous Articles
Received:2026-03-25
Revised:2026-06-18
Published:2027-01-05
Online:2026-11-17
Contact:
YUAN Jihong
通讯作者:
袁计红
作者简介:作者贡献:
金咏梅提出主要研究目标,负责研究构思与设计、文章的质量控制与审查;袁计红负责数据整理、统计学处理,撰写论文;邱霖、宋莉芳、吴雅妮、姜娜娜进行数据的收集与整理、表格的绘制与展示。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2026.0120
| 组别 | 例数 | 年龄( | BMI ( | 文化程度[例(%)] | 病理类型[例(%)] | 腋窝淋巴结清扫数目( | 手术至入组时间( | 上臂周径最大差值( | LTW ( | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 小学及以下 | 初中/高中 | 大专及以上 | 浸润性导管癌 | 浸润性小叶癌 | 其他 | ||||||||
| 对照组 | 109 | 49.1±6.9 | 25.7±3.0 | 10(9.17) | 58(53.21) | 41(37.61) | 93(85.32) | 11(10.09) | 5(4.59) | 12.58±2.31 | 4.36±0.98 | 1.88±0.49 | 1.25±0.14 |
| 干预组 | 110 | 48.6±7.2 | 25.4±3.1 | 12(10.91) | 56(50.91) | 42(38.18) | 95(86.36) | 10(9.09) | 5(4.55) | 12.36±2.15 | 4.25±1.02 | 1.85±0.52 | 1.23±0.15 |
| t(χ2)值 | 0.452 | 0.785 | 1.205a | 0.328a | 0.762 | 0.891 | 0.458 | 0.982 | |||||
| P值 | 0.651 | 0.433 | 0.751 | 0.849 | 0.447 | 0.374 | 0.647 | 0.328 | |||||
Table 1 General information of the two groups
| 组别 | 例数 | 年龄( | BMI ( | 文化程度[例(%)] | 病理类型[例(%)] | 腋窝淋巴结清扫数目( | 手术至入组时间( | 上臂周径最大差值( | LTW ( | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 小学及以下 | 初中/高中 | 大专及以上 | 浸润性导管癌 | 浸润性小叶癌 | 其他 | ||||||||
| 对照组 | 109 | 49.1±6.9 | 25.7±3.0 | 10(9.17) | 58(53.21) | 41(37.61) | 93(85.32) | 11(10.09) | 5(4.59) | 12.58±2.31 | 4.36±0.98 | 1.88±0.49 | 1.25±0.14 |
| 干预组 | 110 | 48.6±7.2 | 25.4±3.1 | 12(10.91) | 56(50.91) | 42(38.18) | 95(86.36) | 10(9.09) | 5(4.55) | 12.36±2.15 | 4.25±1.02 | 1.85±0.52 | 1.23±0.15 |
| t(χ2)值 | 0.452 | 0.785 | 1.205a | 0.328a | 0.762 | 0.891 | 0.458 | 0.982 | |||||
| P值 | 0.651 | 0.433 | 0.751 | 0.849 | 0.447 | 0.374 | 0.647 | 0.328 | |||||
| 分组 | 例数 | 干预前 | 干预后3个月 | 干预后6个月 | 干预后9个月 | 干预后12个月 |
|---|---|---|---|---|---|---|
| 对照组 | 109 | 1.88±0.49 | 1.65±0.45a | 1.38±0.38ab | 1.15±0.31ab | 0.96±0.29ab |
| 干预组 | 110 | 1.85±0.52 | 1.26±0.41ac | 0.95±0.32abc | 0.72±0.28abc | 0.58±0.25abc |
| F值 | F交互=48.526,F组别=42.318,F时间=156.742 | |||||
| P值 | P交互<0.001,P组别<0.001,P时间<0.001 | |||||
Table 2 Comparison of the maximum difference in upper arm circumference between the two groups at different time points
| 分组 | 例数 | 干预前 | 干预后3个月 | 干预后6个月 | 干预后9个月 | 干预后12个月 |
|---|---|---|---|---|---|---|
| 对照组 | 109 | 1.88±0.49 | 1.65±0.45a | 1.38±0.38ab | 1.15±0.31ab | 0.96±0.29ab |
| 干预组 | 110 | 1.85±0.52 | 1.26±0.41ac | 0.95±0.32abc | 0.72±0.28abc | 0.58±0.25abc |
| F值 | F交互=48.526,F组别=42.318,F时间=156.742 | |||||
| P值 | P交互<0.001,P组别<0.001,P时间<0.001 | |||||
| 分组 | 例数 | 干预前 | 干预后3个月 | 干预后6个月 | 干预后9个月 | 干预后12个月 |
|---|---|---|---|---|---|---|
| 对照组 | 109 | 1.25±0.14 | 1.20±0.12a | 1.15±0.10ab | 1.08±0.09ab | 1.02±0.08ab |
| 干预组 | 110 | 1.23±0.15 | 1.12±0.11ac | 1.05±0.09abc | 0.98±0.08abc | 0.92±0.07abc |
| F值 | F交互=28.653,F组别=25.472,F时间=98.631 | |||||
| P值 | P交互<0.001,P组别<0.001,P时间<0.001 | |||||
Table 3 Comparison of LTW between the two groups at different time points
| 分组 | 例数 | 干预前 | 干预后3个月 | 干预后6个月 | 干预后9个月 | 干预后12个月 |
|---|---|---|---|---|---|---|
| 对照组 | 109 | 1.25±0.14 | 1.20±0.12a | 1.15±0.10ab | 1.08±0.09ab | 1.02±0.08ab |
| 干预组 | 110 | 1.23±0.15 | 1.12±0.11ac | 1.05±0.09abc | 0.98±0.08abc | 0.92±0.07abc |
| F值 | F交互=28.653,F组别=25.472,F时间=98.631 | |||||
| P值 | P交互<0.001,P组别<0.001,P时间<0.001 | |||||
| 分组 | 例数 | 干预前 | 干预后3个月 | 干预后6个月 | 干预后9个月 | 干预后12个月 |
|---|---|---|---|---|---|---|
| 对照组 | 109 | 29.12±5.89 | 24.58±4.31a | 20.15±3.89ab | 16.36±3.12ab | 13.58±2.89ab |
| 干预组 | 110 | 28.65±6.23 | 19.36±4.15ac | 14.25±3.28abc | 10.58±2.56abc | 8.23±2.15abc |
| F值 | F交互=62.847,F组别=58.326,F时间=187.563 | |||||
| P值 | P交互<0.001,P组别<0.001,P时间<0.001 | |||||
Table 4 Comparison of total BCLE-SEI scores between the two groups at different time points
| 分组 | 例数 | 干预前 | 干预后3个月 | 干预后6个月 | 干预后9个月 | 干预后12个月 |
|---|---|---|---|---|---|---|
| 对照组 | 109 | 29.12±5.89 | 24.58±4.31a | 20.15±3.89ab | 16.36±3.12ab | 13.58±2.89ab |
| 干预组 | 110 | 28.65±6.23 | 19.36±4.15ac | 14.25±3.28abc | 10.58±2.56abc | 8.23±2.15abc |
| F值 | F交互=62.847,F组别=58.326,F时间=187.563 | |||||
| P值 | P交互<0.001,P组别<0.001,P时间<0.001 | |||||
| 分组 | 例数 | 干预前 | 干预后3个月 | 干预后6个月 | 干预后9个月 | 干预后12个月 |
|---|---|---|---|---|---|---|
| 对照组 | 109 | 64.89±7.98 | 70.25±8.56a | 78.65±9.12ab | 85.36±9.89ab | 92.58±10.23ab |
| 干预组 | 110 | 65.36±8.25 | 78.58±9.12ac | 89.36±9.58abc | 98.25±10.15abc | 105.68±10.52abc |
| F值 | F交互=35.628,F组别=31.475,F时间=142.864 | |||||
| P值 | P交互<0.001,P组别<0.001,P时间<0.001 | |||||
Table 5 Comparison of total FACT-B scores between the two groups at different time points
| 分组 | 例数 | 干预前 | 干预后3个月 | 干预后6个月 | 干预后9个月 | 干预后12个月 |
|---|---|---|---|---|---|---|
| 对照组 | 109 | 64.89±7.98 | 70.25±8.56a | 78.65±9.12ab | 85.36±9.89ab | 92.58±10.23ab |
| 干预组 | 110 | 65.36±8.25 | 78.58±9.12ac | 89.36±9.58abc | 98.25±10.15abc | 105.68±10.52abc |
| F值 | F交互=35.628,F组别=31.475,F时间=142.864 | |||||
| P值 | P交互<0.001,P组别<0.001,P时间<0.001 | |||||
| [1] |
|
| [2] |
|
| [3] |
王玥姣,贾立群,朱世杰. 乳脉通络洗剂治疗乳腺癌相关性上肢淋巴水肿临床观察[J]. 中日友好医院学报, 2014, 28(3): 171-172.
|
| [4] |
安立新,宋光明. 古代文献关于水肿论述的探析[J]. 实用中医内科杂志, 2023, 37(6): 63-65.
|
| [5] |
陈学彰,王斌,陈菊,等. 中医药治疗乳腺癌的临床研究进展[J]. 中医肿瘤学杂志, 2025, 7(4): 26-35.
|
| [6] |
杨杰,闫晓,张玲莉,等. 艾灸对机体免疫调节的研究进展[J]. 中国中医基础医学杂志, 2013, 19(9): 867-868.
|
| [7] |
张芙蓉,杨名,裴晓华,等. 温和灸对乳腺癌术后上肢淋巴水肿的影响[J]. 世界中西医结合杂志, 2020, 15(10): 1934-1937.
|
| [8] |
顾丹丹,周小兰,张旭,等. 循经灸联合气压治疗对乳腺癌相关淋巴水肿的改善效果[J]. 护理学杂志, 2025, 40(13): 62-65, 87. DOI: 10.3870/j.issn.1001-4152.2025.13.062.
|
| [9] |
陈倩倩,刘红静,韩洁. 通络消肿汤合温针灸联合西药治疗乳腺癌术后上肢淋巴水肿41例[J]. 中医研究, 2023, 36(3): 41-45.
|
| [10] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J]. 中国癌症杂志, 2017, 27(9): 695-759.
|
| [11] |
T/CNAS 14-2020乳腺癌术后淋巴水肿预防和护理[S].
|
| [12] |
金咏梅,陆静波,张华春,等. 上海市护理学会《乳腺癌术后淋巴水肿温和灸技术》团体标准解读[J].上海护理, 2025, 25(9): 1-4.
|
| [13] |
陈佳佳,汪立,韩凌华,等. 应用手法淋巴引流综合消肿疗法治疗肢体淋巴水肿的效果观察[J]. 组织工程与重建外科杂志, 2017, 13(6): 322-324, 327.
|
| [14] |
|
| [15] |
|
| [16] |
万崇华,张冬梅,汤学良,等. 乳腺癌患者生命质量测定量表(FACT-B)中文版的修订[J]. 中国心理卫生杂志, 2003, 17(5): 298-300. DOI: 10.3321/j.issn:1000-6729.2003.05.003.
|
| [17] |
国家中医药管理局(医政司). 乳腺癌中医护理方案(试行)[EB/OL]. (2014-03-27)[2026-03-25].
|
| [18] |
ZY/T 001.1-1994中医病证诊断疗效标准[S].
|
| [19] |
沈婧钰,陈笑,石亚楠,等. 中医药治疗乳腺癌术后上肢淋巴水肿的研究进展[J]. 江西中医药, 2020, 51(12): 77-80.
|
| [20] |
王璐瑶,张琼,陈宁净,等. 乳腺癌内分泌治疗中医证候研究[J]. 陕西中医, 2026, 47(6): 761-766.
|
| [21] |
杨丹,司富春. 基于数据挖掘探析中医治疗乳腺癌的证候分布和方药规律[J]. 中国中医基础医学杂志, 2026, 32(2): 395-400.
|
| [22] |
陈明月. 乳腺癌术后上肢淋巴水肿相关危险因素及中医证型分布研究[D]. 保定: 河北大学, 2023.
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
李岩. 温针灸治疗气虚血瘀型乳腺癌术后上肢淋巴水肿的临床观察[D]. 乌鲁木齐: 新疆医科大学, 2024.
|
| [28] |
林韵如. 台湾地区乳腺癌患者中医体质与证型类型分布规律及与受体的相关性研究[D]. 南京: 南京中医药大学, 2013.
|
| [29] |
杨楚琪,梁玮钰,许雪飞,等. 基于"虚虚实实之戒"探讨恶性肿瘤瘀毒证的诊治思路[J]. 中华中医药杂志, 2024, 39(9): 4775-4778.
|
| [30] |
杨名. 温和灸治疗乳腺癌相关性淋巴水肿的临床疗效观察[D]. 北京中医药大学, 2017.
|
| [1] | WANG Qingkun, YANG Wenqing, HAN Yue, ZHANG Yu, ZHU Lu, WANG Yubing, WANG Shuhao, ZHAO Lei, PIAO Junjie. The Expression of PAIP1 in Breast Cancer and the Effect on the Proliferation, Migration and Glycolysis of Breast Cancer Cells [J]. Chinese General Practice, 2026, 29(33): 4891-4899. |
| [2] | ZHOU Qianmei, MIAO Kali, ZHONG Yongming, ZHANG Fuman, ZHANG Zhe, LI Chengyi. Gas6 Expression in Breast Cancer and Correlation with Clinical Pathological Features and Prognosis [J]. Chinese General Practice, 2025, 28(35): 4449-4456. |
| [3] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
| [4] | LUO Yunzhao, JIANG Hongchuan, XU Feng. Predicting Response to Neoadjuvant Therapy in Breast Cancer Using Deep Learning on Primary Core Needle Biopsy Slides [J]. Chinese General Practice, 2025, 28(19): 2407-2413. |
| [5] | DENG Yaqian, CAO Chunli, MA Jinmei, LI Wenxiao, XU Zelin, CHENG Jing, LI Jun. Predictive Value of S-Detect Combined with Virtual Touch Tissue Imaging Quantification in Axillary Lymph Node Metastasis of Breast Cancer [J]. Chinese General Practice, 2025, 28(17): 2149-2155. |
| [6] | JING Tao, DAI Yongmei, LUO Jianying, LUO Wei, JI Yelinfan, PENG Chi, ZHANG Cuijun, CAO Yanjun, ZHENG Qing, HUANG Yu, SHEN Hejun. The Body Mass Index, Dietary Knowledge Acquisition Level, Sedentary Time and Influencing Factors among Chinese High School Students [J]. Chinese General Practice, 2025, 28(16): 2025-2032. |
| [7] | WU Mengjuan, ZHANG Tao, GAO Chunjie, ZHAO Ting, WANG Lei. Joint-modeling of Estradiol Levels and Survival Data of Breast Cancer Patients in the Case-cohort Design [J]. Chinese General Practice, 2025, 28(14): 1765-1772. |
| [8] | HE Yun, FAN Huanfang, MA Pan, XU Shaoqing, YANG Liu, JIN Mingzhe, ZHANG Mingrui, CHEN Jiaqi. Effect of Postoperative Upper Extremity Lymphedema after Breast Cancer Treated with Different Acupuncture and Moxibustion Therapies: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(14): 1788-1794. |
| [9] | TU Shuting, LIN Jiaying, ZHUANG Jinyang, XIANG Jingnan, WEI Dongshuai, XIE Yong, JIA Jie. Incidence and Related Factors of Post-stroke Cognitive Impairment: a Multicenter Cross-sectional Study Based on Full-cycle Rehabilitation in Stroke [J]. Chinese General Practice, 2024, 27(23): 2829-2837. |
| [10] | LIN Jiaying, TU Shuting, LIN Jiali, ZHOU Yuxin, HE Xinyuan, JIA Jie. Correlation between Somatosensory and Motor Function in Stroke Patients of Different Age Groups and Thoughts on Full-cycle Rehabilitation: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2024, 27(23): 2838-2845. |
| [11] | LI Xingyang, SUN Wanqi, YIN Mengjie, DOU Tingting, LYU Yili, XU Wei, ZHA Zhenqiu. Sleep Quality and Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease and Their Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2024, 27(20): 2437-2444. |
| [12] | JIANG Qixia, ZHOU Jihong, CHEN Kesu, HONG Yanyan, PENG Qing, ZHAN Yingying, XIE Yijie, SUN Ying, WANG Zujing. Pressure Injuries among Adult Inpatients in 46 Tertiary Hospitals in China: Epidemiological Characteristics and Predictive Value of the Braden Scale [J]. Chinese General Practice, 2023, 26(18): 2195-2202. |
| [13] | SHEN Aomei, LU Qian, FU Xin, WEI Xiaoxia, BIAN Jingru, ZHANG Liyuan, QIANG Wanmin, PANG Dong. Constructing a Risk Prediction Model of Breast Cancer-related Lymphedema Based on a Meta-analysis of Prospective Cohort Studies [J]. Chinese General Practice, 2023, 26(17): 2078-2088. |
| [14] | HU Huachao, CHEN Xianya, XIE Siyuan, XIA Zhen, XIAO Hua. Clinical Characteristics and Treatment of Atrial Fibrillation and Heart Failure: a Multicenter Survey [J]. Chinese General Practice, 2023, 26(05): 541-549. |
| [15] | Qixia JIANG, Yijie XIE, Yuxuan BAI, Haixia FENG, Qianzhu CHEN, Defeng CHEN, Yanhong GAO, Xuehong WANG, Yanshuang ZHANG, Xiaohong PAN, Yingchun PAN, Jing ZHAO, Jinmei YU, Huijuan SUO, Yanyan HONG, Yingying ZHAN, Dongmei LI, Haiyan LIU, Xia LI, Dan KUANG, Qing PENG, Jing WANG, Ping YU, Rui CHEN, Yunmin CAI, Ling HUANG, Zujing WANG, Guangyang WANG, Jingping HAO, Dongmei ZHU. Prevalence and Epidemiologic Features of Skin Injuries in Chinese Older Adults: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2022, 25(21): 2569-2576. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||